Early evidence links some Alzheimer’s Disease medications to small cognitive gains in children with autism and low IQ, ...

Please provide your email address to receive an email when new articles are posted on . Response rates on the SRS-2 and CGI-S were significantly higher in those given memantine. Memantine was also ...

For nearly a decade the conventional formulation of memantine has been helpful for treating patients with AD, especially those with advanced stages of the disease. Treatment with memantine has been ...

Clinical trials have shown the benefits of cholinesterase inhibitors for the treatment of mild-to-moderate Alzheimer's disease. It is not known whether treatment benefits continue after the ...

Memantine is approved to treat moderate to severe Alzheimer's disease and other dementias. Evidence suggests that it might also be useful with bipolar disorder, depression, schizophrenia and much more ...

MONDAY, Dec. 2, 2024 (HealthDay News) -- Discontinuing cholinesterase inhibitors upon memantine initiation is not associated ...

Clinical trials in Alzheimer disease (AD) generally allow participants to continue receiving concomitant medications, including cholinesterase inhibitors (ChEIs) and memantine, if the dose is stable.

(HealthDay News) — The combination of memantine plus sertraline is efficacious for major depressive disorder, according to a study published in the Journal of Clinical Pharmacy and Therapeutics.

Effects of memantine in anxiety disorders are inconsistent. The authors note that studies of memantine in generalized anxiety disorder (GAD) have been “disappointing.” However, the drug showed ...